Pfizer Forges Research Partnership In China Aimed At Fighting Cancers Prevalent In Asia
This article was originally published in The Pink Sheet Daily
Executive Summary
Scientists from Pfizer and Crown Bioscience join forces to research and develop novel treatments, including therapeutics to combat liver cancer, the second leading cause of cancer death in China.